A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer

Changyu Shen, Yiwen Huang, Yunlong Liu, Guohua Wang, Yuming Zhao, Zhiping Wang, Mingxiang Teng, Yadong Wang, David A. Flockhart, Todd C. Skaar, Pearlly Yan, Kenneth P. Nephew, Tim H.M. Huang, Lang Li

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Estrogens regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. Dynamic gene expression changes have been shown to characterize the breast cancer cell response to estrogens, the every molecular mechanism of which is still not well understood.Results: We developed a modulated empirical Bayes model, and constructed a novel topological and temporal transcription factor (TF) regulatory network in MCF7 breast cancer cell line upon stimulation by 17β-estradiol stimulation. In the network, significant TF genomic hubs were identified including ER-alpha and AP-1; significant non-genomic hubs include ZFP161, TFDP1, NRF1, TFAP2A, EGR1, E2F1, and PITX2. Although the early and late networks were distinct (<5% overlap of ERα target genes between the 4 and 24 h time points), all nine hubs were significantly represented in both networks. In MCF7 cells with acquired resistance to tamoxifen, the ERα regulatory network was unresponsive to 17β-estradiol stimulation. The significant loss of hormone responsiveness was associated with marked epigenomic changes, including hyper- or hypo-methylation of promoter CpG islands and repressive histone methylations.Conclusions: We identified a number of estrogen regulated target genes and established estrogen-regulated network that distinguishes the genomic and non-genomic actions of estrogen receptor. Many gene targets of this network were not active anymore in anti-estrogen resistant cell lines, possibly because their DNA methylation and histone acetylation patterns have changed.

Original languageEnglish (US)
Article number67
JournalBMC Systems Biology
Volume5
DOIs
StatePublished - May 9 2011

Fingerprint

Estrogen Receptor
Estrogen
Empirical Bayes
Regulatory Networks
Breast Cancer
Estrogen Receptors
Estrogens
Breast Neoplasms
Methylation
Genomics
Estradiol
Cell
Transcription Factor
Transcription factors
Gene
Genes
Cells
Histones
Target
Gene Expression

ASJC Scopus subject areas

  • Structural Biology
  • Modeling and Simulation
  • Molecular Biology
  • Computer Science Applications
  • Applied Mathematics

Cite this

A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer. / Shen, Changyu; Huang, Yiwen; Liu, Yunlong; Wang, Guohua; Zhao, Yuming; Wang, Zhiping; Teng, Mingxiang; Wang, Yadong; Flockhart, David A.; Skaar, Todd C.; Yan, Pearlly; Nephew, Kenneth P.; Huang, Tim H.M.; Li, Lang.

In: BMC Systems Biology, Vol. 5, 67, 09.05.2011.

Research output: Contribution to journalArticle

Shen, Changyu ; Huang, Yiwen ; Liu, Yunlong ; Wang, Guohua ; Zhao, Yuming ; Wang, Zhiping ; Teng, Mingxiang ; Wang, Yadong ; Flockhart, David A. ; Skaar, Todd C. ; Yan, Pearlly ; Nephew, Kenneth P. ; Huang, Tim H.M. ; Li, Lang. / A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer. In: BMC Systems Biology. 2011 ; Vol. 5.
@article{d2cd59af5c634dd8b27deb9bb2818f8c,
title = "A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer",
abstract = "Background: Estrogens regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. Dynamic gene expression changes have been shown to characterize the breast cancer cell response to estrogens, the every molecular mechanism of which is still not well understood.Results: We developed a modulated empirical Bayes model, and constructed a novel topological and temporal transcription factor (TF) regulatory network in MCF7 breast cancer cell line upon stimulation by 17β-estradiol stimulation. In the network, significant TF genomic hubs were identified including ER-alpha and AP-1; significant non-genomic hubs include ZFP161, TFDP1, NRF1, TFAP2A, EGR1, E2F1, and PITX2. Although the early and late networks were distinct (<5{\%} overlap of ERα target genes between the 4 and 24 h time points), all nine hubs were significantly represented in both networks. In MCF7 cells with acquired resistance to tamoxifen, the ERα regulatory network was unresponsive to 17β-estradiol stimulation. The significant loss of hormone responsiveness was associated with marked epigenomic changes, including hyper- or hypo-methylation of promoter CpG islands and repressive histone methylations.Conclusions: We identified a number of estrogen regulated target genes and established estrogen-regulated network that distinguishes the genomic and non-genomic actions of estrogen receptor. Many gene targets of this network were not active anymore in anti-estrogen resistant cell lines, possibly because their DNA methylation and histone acetylation patterns have changed.",
author = "Changyu Shen and Yiwen Huang and Yunlong Liu and Guohua Wang and Yuming Zhao and Zhiping Wang and Mingxiang Teng and Yadong Wang and Flockhart, {David A.} and Skaar, {Todd C.} and Pearlly Yan and Nephew, {Kenneth P.} and Huang, {Tim H.M.} and Lang Li",
year = "2011",
month = "5",
day = "9",
doi = "10.1186/1752-0509-5-67",
language = "English (US)",
volume = "5",
journal = "BMC Systems Biology",
issn = "1752-0509",
publisher = "BioMed Central",

}

TY - JOUR

T1 - A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer

AU - Shen, Changyu

AU - Huang, Yiwen

AU - Liu, Yunlong

AU - Wang, Guohua

AU - Zhao, Yuming

AU - Wang, Zhiping

AU - Teng, Mingxiang

AU - Wang, Yadong

AU - Flockhart, David A.

AU - Skaar, Todd C.

AU - Yan, Pearlly

AU - Nephew, Kenneth P.

AU - Huang, Tim H.M.

AU - Li, Lang

PY - 2011/5/9

Y1 - 2011/5/9

N2 - Background: Estrogens regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. Dynamic gene expression changes have been shown to characterize the breast cancer cell response to estrogens, the every molecular mechanism of which is still not well understood.Results: We developed a modulated empirical Bayes model, and constructed a novel topological and temporal transcription factor (TF) regulatory network in MCF7 breast cancer cell line upon stimulation by 17β-estradiol stimulation. In the network, significant TF genomic hubs were identified including ER-alpha and AP-1; significant non-genomic hubs include ZFP161, TFDP1, NRF1, TFAP2A, EGR1, E2F1, and PITX2. Although the early and late networks were distinct (<5% overlap of ERα target genes between the 4 and 24 h time points), all nine hubs were significantly represented in both networks. In MCF7 cells with acquired resistance to tamoxifen, the ERα regulatory network was unresponsive to 17β-estradiol stimulation. The significant loss of hormone responsiveness was associated with marked epigenomic changes, including hyper- or hypo-methylation of promoter CpG islands and repressive histone methylations.Conclusions: We identified a number of estrogen regulated target genes and established estrogen-regulated network that distinguishes the genomic and non-genomic actions of estrogen receptor. Many gene targets of this network were not active anymore in anti-estrogen resistant cell lines, possibly because their DNA methylation and histone acetylation patterns have changed.

AB - Background: Estrogens regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. Dynamic gene expression changes have been shown to characterize the breast cancer cell response to estrogens, the every molecular mechanism of which is still not well understood.Results: We developed a modulated empirical Bayes model, and constructed a novel topological and temporal transcription factor (TF) regulatory network in MCF7 breast cancer cell line upon stimulation by 17β-estradiol stimulation. In the network, significant TF genomic hubs were identified including ER-alpha and AP-1; significant non-genomic hubs include ZFP161, TFDP1, NRF1, TFAP2A, EGR1, E2F1, and PITX2. Although the early and late networks were distinct (<5% overlap of ERα target genes between the 4 and 24 h time points), all nine hubs were significantly represented in both networks. In MCF7 cells with acquired resistance to tamoxifen, the ERα regulatory network was unresponsive to 17β-estradiol stimulation. The significant loss of hormone responsiveness was associated with marked epigenomic changes, including hyper- or hypo-methylation of promoter CpG islands and repressive histone methylations.Conclusions: We identified a number of estrogen regulated target genes and established estrogen-regulated network that distinguishes the genomic and non-genomic actions of estrogen receptor. Many gene targets of this network were not active anymore in anti-estrogen resistant cell lines, possibly because their DNA methylation and histone acetylation patterns have changed.

UR - http://www.scopus.com/inward/record.url?scp=79955690126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955690126&partnerID=8YFLogxK

U2 - 10.1186/1752-0509-5-67

DO - 10.1186/1752-0509-5-67

M3 - Article

C2 - 21554733

AN - SCOPUS:79955690126

VL - 5

JO - BMC Systems Biology

JF - BMC Systems Biology

SN - 1752-0509

M1 - 67

ER -